Progenics Pharmaceuticals Inc. Debt to Equity Ratio 2010-2020 | PGNX

Current and historical debt to equity ratio values for Progenics Pharmaceuticals Inc. (PGNX) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Progenics Pharmaceuticals Inc. debt/equity for the three months ending March 31, 2020 was .
Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2020-03-31 $0.07B $0.03B 2.21
2019-12-31 $0.07B $0.05B 1.57
2019-09-30 $0.07B $0.06B 1.33
2019-06-30 $0.08B $0.07B 1.10
2019-03-31 $0.08B $0.08B 0.97
2018-12-31 $0.07B $0.10B 0.68
2018-09-30 $0.07B $0.12B 0.59
2018-06-30 $0.08B $0.06B 1.27
2018-03-31 $0.08B $0.06B 1.32
2017-12-31 $0.08B $0.06B 1.30
2017-09-30 $0.09B $0.06B 1.55
2017-06-30 $0.10B $0.08B 1.29
2017-03-31 $0.09B $0.09B 1.05
2016-12-31 $0.09B $0.11B 0.90
2016-09-30 $0.05B $0.11B 0.41
2016-06-30 $0.04B $0.07B 0.60
2016-03-31 $0.04B $0.08B 0.54
2015-12-31 $0.04B $0.09B 0.45
2015-09-30 $0.04B $0.10B 0.42
2015-06-30 $0.04B $0.11B 0.35
2015-03-31 $0.04B $0.12B 0.30
2014-12-31 $0.04B $0.13B 0.29
2014-09-30 $0.04B $0.14B 0.27
2014-06-30 $0.03B $0.10B 0.35
2014-03-31 $0.03B $0.11B 0.31
2013-12-31 $0.04B $0.08B 0.45
2013-09-30 $0.04B $0.09B 0.41
2013-06-30 $0.04B $0.09B 0.39
2013-03-31 $0.04B $0.07B 0.57
2012-12-31 $0.01B $0.07B 0.15
2012-09-30 $0.01B $0.04B 0.18
2012-06-30 $0.01B $0.05B 0.10
2012-03-31 $0.01B $0.06B 0.09
2011-12-31 $0.01B $0.07B 0.12
2011-09-30 $0.01B $0.08B 0.11
2011-06-30 $0.01B $0.09B 0.09
2011-03-31 $0.07B $0.03B 2.24
2010-12-31 $0.01B $0.05B 0.22
2010-09-30 $0.01B $0.07B 0.13
2010-06-30 $0.01B $0.08B 0.09
2010-03-31 $0.01B $0.09B 0.09
2009-12-31 $0.01B $0.11B 0.06
2009-09-30 $0.01B $0.10B 0.12
2009-06-30 $0.02B $0.11B 0.14
2009-03-31 $0.02B $0.12B 0.15